Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00504530
Status:
COMPLETED
Last Update Posted:
2017-01-04
First Post:
2007-07-18
Brief Title:
r-hLIF for Improving Embryo Implantation in IVF
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany
Study Overview
Official Title:
A Randomised Double-blind Placebo Controlled Proof of Concept Study to Assess the Efficacy Safety and Acceptability of r-hLIF for Improving Embryo Implantation Following in Vitro Fertilisation IVF and Embryo Transfer ET in Women With Recurrent Implantation Failure
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was designed to obtain pilot clinical evidence of the efficacy safety and acceptability of r-hLIF administered during the luteal phase after IVFintra-cytoplasmic sperm injection ICSI and ET for improving embryo implantation in infertile women with a history of at least three implantation failures following ART Based on LIF expression patterns and experimental data from animal research a role of LIF in embryo implantation is anticipated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None